SCHEMBL29609334

SCHEMBL29609334

CN(C)c1ccc(C=C2C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.70
MAPT P10636 9/20 0.63
ALDH1A1 P00352 7/20 0.63
APP P05067 6/20 0.63
SNCA P37840 6/20 0.63
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
MAPK1 P28482 3/20 0.63
TDP1 Q9NUW8 3/20 0.63
PDGFRB P09619 2/20 0.63
LMNA P02545 2/20 0.63
HPGD P15428 2/20 0.63
PKM P14618 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
NPC1 O15118 1/20 0.63
GMNN O75496 1/20 0.63
MTOR P42345 1/20 0.63
RAB9A P51151 1/20 0.63
BLM P54132 1/20 0.63
PMP22 Q01453 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1454792 1.00 MIF (0.70) MIFMAPTALDH1A1APPSNCA
SCHEMBL34474369 0.95 MIF (0.65) MIFMAPTALDH1A1APPSNCA
SCHEMBL25850280 0.87 MIF (0.59) MIFMAPTALDH1A1APPSNCA
SCHEMBL22625286 0.84 LCK (0.66) MAPTALDH1A1APPMEN1KMT2A
SCHEMBL136295 0.83 MAPT (0.59) MIFMAPTALDH1A1APPSNCA
SCHEMBL2716738 0.82 LCK (0.51) MIFMAPTALDH1A1APPSNCA
SCHEMBL19136641 0.82 MIF (0.54) MIFMAPTALDH1A1APPSNCA
SCHEMBL31022832 0.82 MAPT (0.57) MIFMAPTALDH1A1APPSNCA
SCHEMBL19136640 0.82 MIF (0.54) MIFMAPTALDH1A1APPSNCA
SCHEMBL10134134 0.81 KMT2A (0.53) MIFMAPTALDH1A1APPSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667895-B2 Methods and devices related to controlled delivery of phages as a theranostic tool THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-06-06 US claimed
US-20250102513-A1 KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL Encodia, Inc. (US) 2025-03-27 US disclosed
US-20250043290-A1 RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF CORNELL UNIVERSITY 2025-02-06 US disclosed
US-20240294903-A1 RNA-APTAMER-SENSORS Senseup Gmbh (DE) 2024-09-05 US disclosed
CN-116457472-A RNA aptamer sensor 森斯艾普有限公司 2023-07-18 CN disclosed
EP-4208551-A1 RNA-APTAMER-SENSORS SenseUp GmbH (DE) 2023-07-12 EP disclosed
US-11667895-B2 Methods and devices related to controlled delivery of phages as a theranostic tool THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-06-06 US disclosed
WO-2023097013-A1 RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF CORNELL UNIVERSITY (US) 2023-06-01 WO disclosed
US-11629131-B2 Coupled recognition/detection system for in vivo and in vitro use CORNELL UNIVERSITY (US) 2023-04-18 US disclosed
US-11453646-B2 Methods for RNA detection and quantification CORNELL UNIVERSITY (US) 2022-09-27 US disclosed
WO-2022049010-A1 RNA-APTAMER-SENSORS Senseup Gmbh (DE) 2022-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453646-B2 Methods for RNA detection and quantification SNRPE, NSUN3, EFTUD2 MIF 4678/4885MAPT 2839/4885ALDH1A1 3186/4885
US-11629131-B2 Coupled recognition/detection system for in vivo and in vitro use DCLRE1B, TLR9, APEX1 MIF 4471/4885MAPT 4039/4885ALDH1A1 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.